Sale!

RETATRUTIDE PEPTIDE 10mg (Medical Pharma)

Original price was: $159.00.Current price is: $119.00.

Retatrutide Research Applications

Retatrutide-labeled research material may be relevant to laboratory work involving:

  • Peptide characterization
  • Receptor-binding research
  • GIP receptor signaling
  • GLP-1 receptor signaling
  • Glucagon receptor signaling
  • Triple-agonist pharmacology
  • Analytical method development
  • Stability research
  • Comparative peptide studies
  • Metabolic-receptor research

The research designation is important. A laboratory product should remain within laboratory and analytical applications and should not be marketed with human dosing, injection, weight-loss treatment, or disease-treatment instructions.

RETATRUTIDE PEPTIDE 10mg (Medical Pharma)

Retatrutide 10 mg Product Details

Product Specification Details
Compound Retatrutide
Amount 10 mg
Vial Size 3 mL
Category Research peptide
Price $120 USD
Intended Use Laboratory and analytical research
Human Use Not intended for human use
FDA-Approved Drug No
Brand Association Generic research material; no Lilly affiliation

Retatrutide 10 mg — $119 USD

Can You Buy Retatrutide?

Yes, retatrutide-labeled material is available for laboratory research, including research peptide preparations such as the 10 mg product described on this page.

However, there is currently no FDA-approved Retatrutide prescription drug available for consumers.

That distinction matters.

When researchers purchase Retatrutide material, they are purchasing a laboratory product intended for research applications—not an approved obesity medication, diabetes medication, compounded prescription, or substitute for Lilly’s investigational clinical-trial material.

As of August 2026, Lilly still describes Retatrutide as an investigational triple GIP, GLP-1, and glucagon receptor agonist. The company plans to submit a Biologics License Application to FDA in Q1 2027.

Retatrutide 10 mg for Research

Our Retatrutide 10 mg research vial is intended for researchers studying peptide chemistry, receptor pharmacology, analytical characterization, or other legitimate laboratory applications.

The product format provides:

  • 10 mg retatrutide-labeled research material
  • 3 mL vial format
  • $119 USD listed price
  • Compact laboratory storage format
  • Research-only labeling
  • No association with an approved pharmaceutical brand

Why Researchers Are Interested in Retatrutide

Retatrutide, also known as LY3437943, has attracted extensive scientific attention because it activates three metabolic hormone receptors:

  • GIP receptor
  • GLP-1 receptor
  • Glucagon receptor

This triple-receptor pharmacology distinguishes retatrutide from GLP-1-only compounds and dual GIP/GLP-1 agonists.

Lilly’s Phase 3 TRIUMPH-1 trial reported substantial weight reduction in clinical research participants, including an average 28.3% reduction at 80 weeks in the 12 mg group under the reported efficacy estimand. These clinical findings concern Lilly’s investigational product and should not be interpreted as performance claims for research materials sold by unrelated suppliers.

Retatrutide Research Applications

Retatrutide-labeled research material may be relevant to laboratory work involving:

  • Peptide characterization
  • Receptor-binding research
  • GIP receptor signaling
  • GLP-1 receptor signaling
  • Glucagon receptor signaling
  • Triple-agonist pharmacology
  • Analytical method development
  • Stability research
  • Comparative peptide studies
  • Metabolic-receptor research

The research designation is important. A laboratory product should remain within laboratory and analytical applications and should not be marketed with human dosing, injection, weight-loss treatment, or disease-treatment instructions.

Your Cart

Your Cart

Your Cart is Empty

Start Shopping
Continue Shopping
Payment Details
Sub Total $0.00